Similar articles

• Correlation of serum anti-delta with intrahepatic HBV and HDV antigens in patients with chronic active hepatitis.

  Caporaso N, Di Sapio M, Del Vecchio-Blanco C, Coltorti M. Caporaso N, et al. Prog Clin Biol Res. 1987;234:137-44. Prog Clin Biol Res. 1987. PMID: 3628372 No abstract available.
• Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference.

  Jardi R, Rodriguez F, Buti M, Costa X, Cotrina M, Galimany R, Esteban R, Guardia J. Jardi R, et al. Hepatology. 2001 Aug;34(2):404-10. doi: 10.1053/jhep.2001.26511. Hepatology. 2001. PMID: 11481626
• Alpha 2 recombinant interferon in the treatment of chronic hepatitis delta virus (HDV) hepatitis.

  Rosina F, Saracco G, Lattore V, Quartarone V, Rizzetto M, Verme G, Trinchero P, Sansalvadore F, Smedile A. Rosina F, et al. Prog Clin Biol Res. 1987;234:299-303. Prog Clin Biol Res. 1987. PMID: 3628384 No abstract available.
• [Serologic markers of hepatitis B virus. Recent progress].

  Mora Pérez I, Porres Cubero JC, Carreño García V. Mora Pérez I, et al. Rev Clin Esp. 1984 Apr 15;173(1):9-14. Rev Clin Esp. 1984. PMID: 6330799 Review. Spanish. No abstract available.
• [Hepatitis B virus infection: current developments].

  van Ditzhuysen JM, van Loon AM, Yap SH. van Ditzhuysen JM, et al. Ned Tijdschr Geneeskd. 1983 Nov 26;127(48):2193-8. Ned Tijdschr Geneeskd. 1983. PMID: 6318129 Review. Dutch. No abstract available.